Literature DB >> 10833780

Pathogenic effects of a high peritoneal transport rate.

J Heaf1.   

Abstract

Recent studies have shown that patients with high peritoneal transport characteristics have substantially increased morbidity and mortality. This finding is counter-intuitive, since HTs will a priori achieve higher clearances. There are many possible causes: increased protein losses with consequent hypoalbuminemia; poor ultrafiltration capacity causing fluid retention, ventricular hypertrophy and hypertension; increased glucose absorption leading to anorexia, hyperinsulinism, and local AGE formation; and the development of an atherogenic lipid profile. While common pathogenic causes of high peritoneal transport and atherosclerosis have been hypothesized, it is more likely that CAPD as currently practiced is unsuitable for HTs, who should be switched to HD or NIPD. Renal and peritoneal clearances have different clinical effects and should be assessed separately. Current measures of dialysis adequacy, such as total Kt/V, do not therefore describe the patient's clinical situation accurately and are insufficient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833780     DOI: 10.1046/j.1525-139x.2000.00051.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  2 in total

1.  High peritoneal transport status is not an independent risk factor for high mortality in patients treated with automated peritoneal dialysis.

Authors:  Tae Ik Chang; Jung Tak Park; Dong Hyung Lee; Ju Hyun Lee; Tae Hyun Yoo; Beom Seok Kim; Shin-Wook Kang; Ho Yung Lee; Kyu Hun Choi
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

2.  Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients.

Authors:  Yuanyuan Shi; Hao Yan; Jiangzi Yuan; He Zhang; Jiaying Huang; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  BMC Nephrol       Date:  2018-05-23       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.